Related Experiment Video
Updated: Jul 3, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Possible involvement of cathepsin B released by microglia in methylmercury-induced cerebellar pathological changes in
Misao Sakamoto1, Ken-ichiro Miyamoto, Zhou Wu
1Laboratory of Oral Aging Science, Faculty of Dental Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan.
Abstract:
There is increasing evidence that cathepsin B (CB), a lysosomal cysteine protease, is one of the toxic molecules that are secreted by activated microglia. We herein provide evidence that CB released by activated microglia may play a role in the methylmercury (MeHg)-induced pathological changes observed in the cerebellum of the adult rat. Pathological changes tended to progress slowly after treatment with MeHg (5 mg/kg) for 12 consecutive days. At 5 days after the final treatment of MeHg, there was a mild pyknotic change of the granule cells, whereas a marked accumulation of activated microglia was observed in the granule cell layer of the lingual and central lobe. At 8 days after the final treatment, intense pyknotic changes of the granule cells and the accumulation of activated microglia were observed throughout the cerebellar vermis. CB first significantly increased at 3 days after the final treatment of MeHg as the mature form. CB mainly increased in activated microglia which accumulated in the granule cell layer. The coadministration of CA074, an irreversible CB inhibitor, with MeHg significantly reduced the severity of pyknotic changes of the granule cells. Furthermore, primary cultured microglia secreted the mature CB in the culture medium following cellular activation. These observations strongly suggest that CB secreted by activated microglia is thus closely associated with the MeHg-induced severe pyknotic changes of the cerebellar granule cells. The treatment of CA074 could be a potentially effective therapeutic intervention to prevent the pathological changes in the cerebellum caused by ingestion of MeHg-contaminated food.
Insights
Cathepsin B (CB) released by activated microglia contributes to methylmercury (MeHg) brain damage. Inhibiting CB with CA074 protected cerebellar granule cells from MeHg toxicity.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Activated microglia release toxic molecules, including cathepsin B (CB).
- Methylmercury (MeHg) exposure causes cerebellar pathology.
Purpose of the Study:
- To investigate the role of microglial cathepsin B (CB) in methylmercury (MeHg)-induced cerebellar damage in adult rats.
Main Methods:
- Rats were treated with MeHg, and pathological changes in the cerebellum were assessed.
- Cathepsin B levels in activated microglia were measured.
- The effect of a CB inhibitor (CA074) on MeHg toxicity was evaluated.
- Primary cultured microglia were used to study CB secretion.
Main Results:
- MeHg treatment led to progressive pyknotic changes in cerebellar granule cells and microglial activation.
- Mature cathepsin B levels significantly increased in activated microglia following MeHg exposure.
- Co-administration of CA074 with MeHg significantly reduced the severity of granule cell damage.
- Activated microglia in culture secreted mature CB.
Conclusions:
- Cathepsin B secreted by activated microglia is closely associated with MeHg-induced cerebellar granule cell damage.
- CA074 treatment may be a potential therapeutic strategy to prevent MeHg neurotoxicity.

